HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Koblet Selected Research

RO 4882224

10/2009The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Koblet Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
01/2017
1Cognitive Dysfunction
10/2009

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
01/2017
1Amyloid beta-PeptidesIBA
01/2017
1RO 4882224IBA
10/2009
13- bromo- 10- difluoromethyl- 9H- imidazo(1,5- a)(1,2,4)triazolo(1,5- d)(1,4)benzodiazepineIBA
10/2009

Therapy/Procedure

1Therapeutics
01/2017